178 related articles for article (PubMed ID: 29476681)
21. Immunohistochemical detection of phosphorylated JNK, p38 MAPK, and ERK5 in ameloblastic tumors.
Kumamoto H; Ooya K
J Oral Pathol Med; 2007 Oct; 36(9):543-9. PubMed ID: 17850438
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical analysis of hMLH1 and hMSH2 proteins in serous ovarian tumours.
Stasikowska-Kanicka O; Stawerski P; Wagrowska-Danilewicz M; Danilewicz M
Pol J Pathol; 2009; 60(4):174-8. PubMed ID: 20072951
[TBL] [Abstract][Full Text] [Related]
23. Loss of expression of DNA repair enzymes MGMT, hMLH1, and hMSH2 during tumor progression in gastric cancer.
Kitajima Y; Miyazaki K; Matsukura S; Tanaka M; Sekiguchi M
Gastric Cancer; 2003; 6(2):86-95. PubMed ID: 12861399
[TBL] [Abstract][Full Text] [Related]
24. Tissue microarray immunohistochemical expression analysis of mismatch repair (hMLH1 and hMSH2 genes) in endometrial carcinoma and atypical endometrial hyperplasia: relationship with microsatellite instability.
Hardisson D; Moreno-Bueno G; Sánchez L; Sarrió D; Suárez A; Calero F; Palacios J
Mod Pathol; 2003 Nov; 16(11):1148-58. PubMed ID: 14614055
[TBL] [Abstract][Full Text] [Related]
25. Is podoplanin expression associated with the proliferative activity of ameloblastomas?
Tjioe KC; Oliveira DT; Soares CT; Lauris JR; Damante JH
Oral Dis; 2012 Oct; 18(7):673-9. PubMed ID: 22443371
[TBL] [Abstract][Full Text] [Related]
26. Unbalanced germ-line expression of hMLH1 and hMSH2 alleles in hereditary nonpolyposis colorectal cancer.
Curia MC; Palmirotta R; Aceto G; Messerini L; Verì MC; Crognale S; Valanzano R; Ficari F; Fracasso P; Stigliano V; Tonelli F; Casale V; Guadagni F; Battista P; Mariani-Costantini R; Cama A
Cancer Res; 1999 Aug; 59(15):3570-5. PubMed ID: 10446963
[TBL] [Abstract][Full Text] [Related]
27. K-Ras gene status and expression of Ras/mitogen-activated protein kinase (MAPK) signaling molecules in ameloblastomas.
Kumamoto H; Takahashi N; Ooya K
J Oral Pathol Med; 2004 Jul; 33(6):360-7. PubMed ID: 15200485
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical detection of the hMLH1 and hMSH2 proteins in hereditary non-polyposis colon cancer and sporadic colon cancer.
Plevová P; Krepelová A; Papezová M; Sedláková E; Curík R; Foretová L; Navrátilová M; Novotný J; Zapletalová J; Palas J; Nieslanik J; Horácek J; Dvorácková J; Kolár Z
Neoplasma; 2004; 51(4):275-84. PubMed ID: 15254659
[TBL] [Abstract][Full Text] [Related]
29. Syndecan-1 (CD138) and Ki-67 expression in different subtypes of ameloblastomas.
Bologna-Molina R; Mosqueda-Taylor A; Lopez-Corella E; Almeida OP; Carrasco-Daza D; Garcia-Vazquez F; Farfan-Morales JE; Irigoyen-Camacho ME; Damián-Matsumura P
Oral Oncol; 2008 Aug; 44(8):805-11. PubMed ID: 18207448
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical expression of mismatch repair genes (hMSH2 and hMLH1) in hepatocellular carcinoma in Egypt.
Helal TE; Khamis NS; El-Sharkawy TM; Nada OH; Radwan NA
APMIS; 2010 Dec; 118(12):934-40. PubMed ID: 21091774
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical detection of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in ameloblastomas.
Kumamoto H; Yamauchi K; Yoshida M; Ooya K
J Oral Pathol Med; 2003 Feb; 32(2):114-20. PubMed ID: 12542835
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of MDM2 protein in ameloblastomas as compared to adenomatoid odontogenic tumor.
Krishna A; Kaveri H; Naveen Kumar RK; Kumaraswamy KL; Shylaja S; Murthy S
J Cancer Res Ther; 2012; 8(2):232-7. PubMed ID: 22842367
[TBL] [Abstract][Full Text] [Related]
33. [Expression of hMSH2 and hMLH1 in stomach cancer and their correlation with Helicobacter pylori infection].
Ma JM; Wang ZH; Liu M; Wang M; Zhang Y; Lu S; Liu LN; Xu GW
Ai Zheng; 2004 May; 23(5):535-9. PubMed ID: 15142449
[TBL] [Abstract][Full Text] [Related]
34. Analysis of hMLH1 and hMSH2 expression in cisplatin-treated ovarian cancer patients.
Magnowska M; Surowiak P; Nowak-Markwitz E; Michalak M; Magnowski P; Rokita W; Kedzia H; Zabel M; Spaczyński M
Ginekol Pol; 2008 Dec; 79(12):826-34. PubMed ID: 19175039
[TBL] [Abstract][Full Text] [Related]
35. [Expression and significance of mismatch repair genes hMLH1 and hMSH2 in sporadic colorectal carcinoma].
Zheng JY; Ren TS; Liu B; Wang MN; Liao HH
Zhonghua Zhong Liu Za Zhi; 2010 Aug; 32(8):590-4. PubMed ID: 21122410
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemistry of proteins for DNA mismatch repair in correlation to prognostic factors of mammarian cancer.
Köster F; Schröer A; Fischer D; Horn AK; Diedrich K; Friedrich M
Oncol Rep; 2007 May; 17(5):1223-7. PubMed ID: 17390069
[TBL] [Abstract][Full Text] [Related]
37. Correlation between hMLH1/hMSH2 and p53 protein expression in sporadic colorectal cancer.
Park IJ; Kim HC; Kim JS; Yu ES; Yu CS; Kim JC
Hepatogastroenterology; 2005; 52(62):450-4. PubMed ID: 15816455
[TBL] [Abstract][Full Text] [Related]
38. Analysis of MLH1 and MSH2 expression in ovarian cancer before and after platinum drug-based chemotherapy.
Samimi G; Fink D; Varki NM; Husain A; Hoskins WJ; Alberts DS; Howell SB
Clin Cancer Res; 2000 Apr; 6(4):1415-21. PubMed ID: 10778972
[TBL] [Abstract][Full Text] [Related]
39. Estrogen up-regulates mismatch repair activity in normal and malignant endometrial glandular cells.
Miyamoto T; Shiozawa T; Kashima H; Feng YZ; Suzuki A; Kurai M; Nikaido T; Konishi I
Endocrinology; 2006 Oct; 147(10):4863-70. PubMed ID: 16825317
[TBL] [Abstract][Full Text] [Related]
40. Loss of protein expression of hMLH1 and hMSH2 with double primary carcinomas of the stomach and colorectum.
Yamamoto M; Taguchi K; Baba H; Endo K; Kohnoe S; Okamura T; Maehara Y
Oncol Rep; 2006 Jul; 16(1):41-7. PubMed ID: 16786121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]